Pharmacogenomics: driving personalized medicine

W Sadee, D Wang, K Hartmann, AE Toland… - Pharmacological …, 2023 - Elsevier
Personalized medicine tailors therapies, disease prevention, and health maintenance to the
individual, with pharmacogenomics serving as a key tool to improve outcomes and prevent …

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in …

P Godoy, NJ Hewitt, U Albrecht, ME Andersen… - Archives of …, 2013 - Springer
This review encompasses the most important advances in liver functions and hepatotoxicity
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …

Cannabinoids and cytochrome P450 interactions

O Zendulka, G Dovrtelova, K Nosková… - Current drug …, 2016 - ingentaconnect.com
Objective: This review consists of three parts, representing three different possibilities of
interactions between cannabinoid receptor ligands of both exogenous and endogenous …

Molecular mechanisms underlying chemical liver injury

X Gu, JE Manautou - Expert reviews in molecular medicine, 2012 - cambridge.org
The liver is necessary for survival. Its strategic localisation, blood flow and prominent role in
the metabolism of xenobiotics render this organ particularly susceptible to injury by …

Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues

P Pavek, Z Dvorak - Current drug metabolism, 2008 - ingentaconnect.com
Numerous members of the cytochrome P450 (CYP) superfamily are induced after exposure
to a variety of xenobiotics in human liver. We have gained considerable mechanistic insights …

Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4

S Takagi, M Nakajima, T Mohri, T Yokoi - Journal of biological chemistry, 2008 - ASBMB
Pregnane X receptor (PXR) is a major transcription factor regulating the inducible
expression of a variety of transporters and drug-metabolizing enzymes, including CYP3A4 …

Nonalcoholic fatty liver disease and diabetes are associated with decreased CYP3A4 protein expression and activity in human liver

R Jamwal, SM De La Monte, K Ogasawara… - Molecular …, 2018 - ACS Publications
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease in the
Western population. We investigated the association of nonalcoholic fatty liver disease …

Single-nucleus RNA-seq2 reveals functional crosstalk between liver zonation and ploidy

ML Richter, IK Deligiannis, K Yin, A Danese… - Nature …, 2021 - nature.com
Single-cell RNA-seq reveals the role of pathogenic cell populations in development and
progression of chronic diseases. In order to expand our knowledge on cellular …

Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions

J Yang, M Liao, M Shou, M Jamei… - Current drug …, 2008 - ingentaconnect.com
In vivo enzyme levels are governed by the rates of de novo enzyme synthesis and
degradation. A current lack of consensus on values of the in vivo turnover half-lives of …

PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo

K Klein, M Thomas, S Winter, AK Nussler… - Clinical …, 2012 - Wiley Online Library
Interindividual variability in cytochrome P450 3A4 (CYP3A4) is believed to be largely
heritable; however, predictive genetic factors have remained scarce. Using a candidate …